PHX 0.00% 5.0¢ pharmx technologies limited

Ann: Corum announces expected non-cash impairment, page-6

  1. 626 Posts.
    lightbulb Created with Sketch. 304
    It's interesting to see that the focus of HC comments so far is on the write-down, but what stood out for me was that the customer response to the new product range has been 'extremely positive'. This is unusually strong language and suggests that COO are very confident on progress with the new product range. This to me should see a bounce in the share price because the company is currently priced for failure.
    As for the write-down, this is largely irrelevant (although it may hold back any dividends this year). At 4c, the goodwill is valued at zero by the market, and if it's Corum's new products that are going to erode the value of these legacy products, then all the better. While I agree that Corum lost its way 18mths+ ago, the investment in mgt and products over the past 18 months appears about to bear fruit. And if this is true, 4c is a long way from what COO company is worth. Looking forward to the results this week and particularly the associated commentary.
 
watchlist Created with Sketch. Add PHX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.